Clinical Trials Logo

Clinical Trial Summary

In this study, the investigators will examine the effects of buprenorphine, as compared to placebo, upon physiological, subjective, and hormonal responses to a stressful speech task and a non-stressful control task in healthy adults. There is strong evidence in support of the role of endogenous opioids and opiates in mediating social behavior in humans and other animals, and particularly, in social distress. Recently it has been shown that buprenorphine, a partial mu-opioid agonist, reduces sensitivity to recognition of fearful facial expressions in humans. Here, the investigators propose to further explore the role of the opioid system in mediating stress responses in humans through the use of buprenorphine. The investigators hypothesize that buprenorphine with reduce both physiological and subjective measures of stress.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01860287
Study type Interventional
Source University of Chicago
Contact
Status Completed
Phase Early Phase 1
Start date September 2013
Completion date January 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05079516 - Neural Basis of Sensory Learning: Brain Regions N/A
Recruiting NCT05953038 - LSD Occupancy of the Serotonin 2A Receptor in the Human Brain Early Phase 1
Completed NCT03541473 - Phosphate Metabolites in Brain of Humans Aged 50+ N/A
Recruiting NCT03289949 - The Neurobiological Effect of 5-HT2AR Modulation Phase 1
Recruiting NCT05739994 - Frontal and Parietal Contributions to Proprioception and Motor Skill Learning N/A
Completed NCT04443647 - Influence of Oxytocin on Approach-avoidance Tendencies to Social and Non-social Stimuli N/A
Recruiting NCT05374460 - Factors Affecting Sensory and Motor Learning N/A
Recruiting NCT05124301 - Neural Basis of Sensory and Motor Learning: Functional Connections N/A